Clonal dynamic changes during the progression of myelodysplastic neoplasms to secondary acute myeloid leukemia: a paired-sample comparison
- 1Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
- 2Division of Hematology-Oncology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei, Taiwan
- 3School of Medicine, Chang Gung University, Taoyuan, Taiwan
Abstract
Patients with myelodysplastic neoplasms (MDS) have a risk of secondary acute myeloid leukemia (sAML) transformation, but previous studies on the paired samples at both MDS and sAML were very rare. This study aimed to investigate the genetic changes during the progression from MDS to sAML by comparing both phases of MDS at diagnosis and sAML in the same individuals. Seventy-nine paired matched samples of MDS at diagnosis and sAML phase were examined for 32 gene mutations commonly occurring in myeloid neoplasms, including epigenetic regulators, cohesin complex, spliceosome complex, signaling pathway, tumor suppressors, and transcription factors by next-generation sequencing. The acquisition of gene mutations involving signaling pathway and transcription factors was significantly more frequent during the progression to sAML compared to other groups of genes. Mutations involving epigenetic regulators, cohesin complex, and spliceosome complex were generally stable or expanded when disease progressed. Loss of gene mutations was rare, and all mutations showed no apparent decline in their variant allele frequencies except STAG2 mutation. RUNX1 mutations were characterized by acquisition or clonal expansion with no loss or decline during disease progression. TP53 mutations exhibit unique mutational complexity and evolutionary patterns. The dynamic distribution pattern of various gene mutations remained similar regardless of BM blast counts at MDS or the rate of disease progression. Our results demonstrated a distinct pattern of clonal changes in different groups of gene mutations during the progression from MDS to sAML.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10238-026-02242-z.
Related
- ARE BONE MARROW MONOCYTE CHARACTERISTICS AT DIAGNOSIS INDICATIVE OF THE EVOLUTION OF MYELODYSPLASTIC NEOPLASMS TO CHRONIC MYELOMONOCYTIC LEUKEMIA?
- Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
- Persistent Malignant Stem Cells Drive Relapse After Transplantation in the Myelodysplastic Neoplasms
- Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms
- Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study
BibTeX
@article{ou2026clonal,
title = {{Clonal dynamic changes during the progression of myelodysplastic neoplasms to secondary acute myeloid leukemia: a paired-sample comparison}},
author = {Che-Wei Ou and Hsiao-Wen Kao and Tung-Liang Lin and Ming-Chung Kuo and Jin-Hou Wu and Hung Chang and Lee-Yung Shih},
journal = {Clinical and Experimental Medicine},
year = {2026},
month = jul,
doi = {10.1007/s10238-026-02242-z},
url = {https://doi.org/10.1007/s10238-026-02242-z},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Clonal dynamic changes during the progression of myelodysplastic neoplasms to secondary acute myeloid leukemia: a paired-sample comparison
AU - Che-Wei Ou
AU - Hsiao-Wen Kao
AU - Tung-Liang Lin
AU - Ming-Chung Kuo
AU - Jin-Hou Wu
AU - Hung Chang
AU - Lee-Yung Shih
PY - 2026
DA - 2026/07/05
JO - Clinical and Experimental Medicine
DO - 10.1007/s10238-026-02242-z
UR - https://doi.org/10.1007/s10238-026-02242-z
AB - Patients with myelodysplastic neoplasms (MDS) have a risk of secondary acute myeloid leukemia (sAML) transformation, but previous studies on the paired samples at both MDS and sAML were very rare. This study aimed to investigate the genetic changes during the progression from MDS to sAML by comparing both phases of MDS at diagnosis and sAML in the same individuals. Seventy-nine paired matched samples of MDS at diagnosis and sAML phase were examined for 32 gene mutations commonly occurring in myeloid neoplasms, including epigenetic regulators, cohesin complex, spliceosome complex, signaling pathway, tumor suppressors, and transcription factors by next-generation sequencing. The acquisition of gene mutations involving signaling pathway and transcription factors was significantly more frequent during the progression to sAML compared to other groups of genes. Mutations involving epigenetic regulators, cohesin complex, and spliceosome complex were generally stable or expanded when disease progressed. Loss of gene mutations was rare, and all mutations showed no apparent decline in their variant allele frequencies except STAG2 mutation. RUNX1 mutations were characterized by acquisition or clonal expansion with no loss or decline during disease progression. TP53 mutations exhibit unique mutational complexity and evolutionary patterns. The dynamic distribution pattern of various gene mutations remained similar regardless of BM blast counts at MDS or the rate of disease progression. Our results demonstrated a distinct pattern of clonal changes in different groups of gene mutations during the progression from MDS to sAML. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10238-026-02242-z.
SN - 1591-8890
SN - 1591-9528
ER -